Related Experiment Video

Updated: Aug 6, 2026

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

Reduced CD34+, renal anemia, and adverse outcomes

Felicita Andreotti, Giulio Coluzzi, Silvia Cecchetti

    American Heart Journal
    |August 1, 2006
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells
    14:22

    Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells

    Published on: July 16, 2011

    Related Experiment Videos

    Last Updated: Aug 6, 2026

    Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
    10:25

    Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

    Published on: August 9, 2019

    Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells
    14:22

    Lentiviral-mediated Knockdown During Ex Vivo Erythropoiesis of Human Hematopoietic Stem Cells

    Published on: July 16, 2011

    Related Concept Videos

    Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

    Acute Kidney Injury IV: Diagnostic Studies and Prevention

    Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...

    Articles linked to this work by shared authors, journal, and citation graph.

    Direct oral anticoagulants in older patients with atrial fibrillation and comorbidities: frailty, renal impairment, acute or chronic coronary syndromes, and acute stroke.

    Polish archives of internal medicine·2026

    Aspirin vs clopidogrel in chronic coronary syndromes: a meta-analysis of ethnic differences.

    European heart journal·2026

    Transcatheter aortic valve thrombosis.

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2026

    Mortality score in chronic coronary syndrome: prediction model from the ISCHEMIA trial.

    European journal of preventive cardiology·2026

    Increased cardiovascular mortality with single antiplatelet therapy in anticoagulation-treated chronic coronary syndrome patients: meta-analysis of randomized trials.

    Polish archives of internal medicine·2026

    ESC Quality Indicators for Post-myocardial infarction Care: Transition and Chronic Coronary Syndrome Phases. Developed in collaboration with the European Association of Preventive Cardiology of the ESC.

    European journal of preventive cardiology·2025

    Cleaner Air for Lower Cardiometabolic Risk: protocol for a double-blind, randomized, sham-controlled trial of HEPA filtration in adults with prediabetes.

    American heart journal·2026

    Cardiac Allograft Vasculopathy and Secondary Outcomes at 1-year in Heart Transplantation from Circulatory Death Donors.

    American heart journal·2026

    Dental Procedures and Associated Risk of Infective Endocarditis.

    American heart journal·2026

    Recurrent myocardial infarction identified by centralized troponin review: Insights from the MINT trial.

    American heart journal·2026

    Pregnancy Outcomes in Women with a History of Myocarditis.

    American heart journal·2026

    HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristics.

    American heart journal·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us